Facebook
Twitter
Telegram
Fehler meldenJounce Therapeutics Finanzdaten 2011-2024 | JNCE
Jahresabschluß Jounce Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
47.5 M | 417 M | 386 M | 209 M | 129 M | 773 M | 513 M | - | - | - | - | - |
Anteile |
51.7 M | 49.9 M | 34.2 M | 33.1 M | 32.6 M | 30.1 M | 30.2 M | - | - | - | - | - |
Kurshistorie |
0.92 | 8.35 | 7 | 8.73 | 3.37 | 12.8 | - | - | - | - | - | - |
Nettogewinn |
-50.9 M | -90.9 M | -43.8 M | 56.8 M | -27.4 M | -16.4 M | -13.7 M | -28.5 M | -10.5 M | - | - | - |
Umsatz |
82 M | 26.9 M | 62.3 M | 148 M | 65.2 M | 71.6 M | 37.2 M | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | 62.3 K | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-52.2 M | -91.1 M | -45.1 M | 52.8 M | -31.3 M | -19.2 M | -14.5 M | -30.4 M | - | - | - | - |
Zinsaufwendungen |
1.46 M | 199 K | 1.29 M | 4.05 M | 3.96 M | 2.81 M | 763 K | 5 K | - | - | - | - |
EBITDA |
-50.2 M | -88.2 M | -41.7 M | 56.7 M | -27.5 M | -14.8 M | -12.5 M | -28.9 M | -15.1 M | - | - | - |
Betriebsaufwand |
134 M | 118 M | 107 M | 95.1 M | 96.5 M | 90.9 M | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
31 M | 29 M | 28.8 M | 27.9 M | 26.4 M | 23.1 M | 16.8 M | 8.27 M | 4.97 M | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Jounce Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
- | 51.7 M | - | 51.6 M | 51.3 M | 51.2 M | 51.2 M | 46 M | 41.7 M | 34.2 M | 34.1 M | 34 M | 33.7 M | 33.1 M | 33 M | 33 M | 32.9 M | 32.6 M | 32.5 M | 32.4 M | 32.2 M | 32.2 M | 32.1 M | 23.5 M | 2.42 M | 2.13 M | 1.99 M | 1.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
- | -31 M | -33.5 M | -37.4 M | - | -30.1 M | -4.01 M | -26.5 M | - | -24.9 M | -28 M | -26.4 M | - | 98.9 M | -6.99 M | -12.4 M | - | -7.64 M | -4.67 M | -13 M | -9.36 M | -4.08 M | -3.38 M | 385 K | 5.47 M | 4.07 M | -12.3 M | -10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatz |
- | - | - | - | - | - | 25.4 M | 1.54 M | - | - | - | - | - | 119 M | 17.4 M | 11 M | - | 14.5 M | 19.4 M | 11.2 M | 13 M | 18.1 M | 20.3 M | 20.3 M | 20.3 M | 16.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
- | -31.4 M | - | -37.5 M | - | -30.1 M | -4.05 M | -26.6 M | - | -25.1 M | -28.2 M | -27.2 M | - | 97.8 M | -8.01 M | -13.5 M | - | -8.74 M | -5.64 M | -13.8 M | -11.6 M | -4.39 M | -3.03 M | -247 K | 4.98 M | 3.82 M | -12.4 M | -10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
- | 412 K | - | 96 K | - | 55 K | 40 K | 49 K | - | 203 K | 285 K | 750 K | - | 1.02 M | 1.03 M | 1.13 M | - | 1.1 M | 966 K | 741 K | - | 721 K | 752 K | 632 K | - | 255 K | 13 K | 11 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -29.8 M | - | -36.9 M | - | -28 M | -4.05 M | -25.8 M | - | -22.5 M | -26.5 M | -26.2 M | - | 101 M | -6.08 M | -12.5 M | - | -5.87 M | -3.73 M | -12.8 M | -11.6 M | -888 K | -437 K | 719 K | 4.98 M | 5.21 M | -11.4 M | -10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
- | 31.4 M | - | 37.5 M | - | 30.1 M | 29.4 M | 28.1 M | - | 25.1 M | 28.2 M | 27.2 M | - | 21.6 M | 25.5 M | 24.5 M | - | 23.3 M | 25 M | 25 M | 24.5 M | 22.5 M | 23.3 M | 20.5 M | 15.3 M | 13.1 M | 12.4 M | 10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
- | 7.65 M | - | 7.35 M | - | 6.85 M | 7.32 M | 7.62 M | - | 7.1 M | 7.23 M | 7.54 M | - | 6.48 M | 7.32 M | 7.19 M | - | 6.52 M | 6.52 M | 6.8 M | - | 5.37 M | 6.13 M | 5.58 M | - | 3.59 M | 5.87 M | 2.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung